Cargando…
Separation of nuclear isomers for cancer therapeutic radionuclides based on nuclear decay after-effects
(177)Lu has sprung as a promising radionuclide for targeted therapy. The low soft tissue penetration of its β(−) emission results in very efficient energy deposition in small-size tumours. Because of this, (177)Lu is used in the treatment of neuroendocrine tumours and is also clinically approved for...
Autores principales: | Bhardwaj, R., van der Meer, A., Das, S. K., de Bruin, M., Gascon, J., Wolterbeek, H. T., Denkova, A. G., Serra-Crespo, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347157/ https://www.ncbi.nlm.nih.gov/pubmed/28287131 http://dx.doi.org/10.1038/srep44242 |
Ejemplares similares
-
Radionuclide generator-based production of therapeutic (177)Lu from its long-lived isomer (177m)Lu
por: Bhardwaj, Rupali, et al.
Publicado: (2019) -
Isomer separation and measurement of nuclear moments with the ISOLDE RILIS
por: Köster, U, et al.
Publicado: (2000) -
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
por: de Kruijff, Robin M., et al.
Publicado: (2015) -
Separation and conversion dynamics of nuclear-spin isomers of gaseous methanol
por: Sun, Zhen-Dong, et al.
Publicado: (2015) -
Fluorescent nuclear track detectors for alpha radiation microdosimetry
por: Kouwenberg, J. J. M., et al.
Publicado: (2018)